Brain protein levels may forecast Post-Surgery confusion in toddlers
NCT ID NCT07192549
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will measure certain brain proteins in 200 children aged 1-3 years undergoing hernia surgery. Researchers want to see if changes in these proteins can predict postoperative delirium and long-term thinking problems. They will also compare two common anesthetics, sevoflurane and propofol, to see if one is safer for the developing brain.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Sevoflurane and propofol (anesthetics)
What this could lead to
If successful, this could help doctors identify children at risk for confusion after surgery and choose safer anesthetics.
What could go wrong
This is a small, early-stage study that only looks for patterns, not a treatment. Results may not apply to all children or surgeries.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTOPERATIVE DELIRIUM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.